Alpha1 anti trypsin
Showing 1 - 25 of >10,000
Intrauterine Growth Restriction in Pre-eclamptic Women
Not yet recruiting
- alpha1 Anti-trypsin
- +2 more
- Alpha1 -Antitrypsin level
- (no location specified)
Nov 18, 2022
COPD Exacerbation Blood and Urine Biomarkers Study
Recruiting
- Chronic Obstructive Pulmonary Disease
- +2 more
-
New York, New YorkColumbia University Medical Center
Oct 11, 2022
Alpha1 Anti-Trypsin Deficiency Trial in United Kingdom (ZF874, Placebo)
Terminated
- Alpha1 Anti-Trypsin Deficiency
- ZF874
- Placebo
-
Manchester, Greater Manchester, United Kingdom
- +4 more
Sep 15, 2022
Eosinophilic Esophagitis Trial (Alpha-proteinase inhibitor)
Not yet recruiting
- Eosinophilic Esophagitis
- Alpha-proteinase inhibitor
- (no location specified)
Aug 2, 2022
Alpha-1 Anti-trypsin Deficiency Trial in Centennial
Completed
- Alpha-1 Anti-trypsin Deficiency
-
Centennial, ColoradoCoram Clinical Trials
Sep 20, 2019
Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes
Recruiting
- Toxicity, Drug
- +2 more
- Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
-
Leiden, NetherlandsLeiden University Medical Center
Aug 16, 2022
HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive
Recruiting
- Drug Monitoring
- Inflammatory Bowel Diseases
- Tumor necrosis factor (TNF)-alpha inhibitors
-
Valladolid, SpainHospital Universitario Rio Hortega
Aug 8, 2023
Alpha 1-Antitrypsin Deficiency, Genetic Disease Trial in United States
Recruiting
- Alpha 1-Antitrypsin Deficiency
- Genetic Disease
-
Birmingham, Alabama
- +9 more
Jul 4, 2022
Pancreatitis, Chronic; Diabetes; Transplant Trial in Minneapolis (etanercept, Alpha 1-Antitrypsin)
Active, not recruiting
- Pancreatitis, Chronic; Diabetes; Transplant
- etanercept
- Alpha 1-Antitrypsin
-
Minneapolis, MinnesotaUniversity of Minnesota
Aug 12, 2022
Immunity in Alpha-1 Anti-trypsin Deficiency
Unknown status
- Alpha 1-Antitrypsin Deficiency
-
Denver, ColoradoNational Jewish Health
Mar 11, 2019
Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)
Recruiting
- Melanoma
- Head and Neck Squamous Cell Carcinoma
- TILT-123
- Avelumab
-
Helsinki, FinlandDocrates Cancer Center
Jul 12, 2022
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Subclinical hypothyroïdism, Hypothalamic-Pituitary-Gonadal Axis
Not yet recruiting
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- +2 more
- Measurement and comparison of leucocytosis and concentrations of CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha in both study arms
- +2 more
-
Kraków, PolandJagiellonian University Medical College, Department of Gynecolog
Apr 29, 2023
Acute Aortic Syndrome, Aortic Dissectio Trial in Nanjing, Beijing (Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic
Recruiting
- Acute Aortic Syndrome
- Aortic Dissectio
- Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic Acid-28D-L-Alanine-28E-L-Proline-28F-L-Alanine-28G-L-Asparagine-
- Blank control
-
Nanjing, Jiangsu, China
- +2 more
Sep 25, 2022
New Regenerative Approach for Dermal Renovation (Karisma)
Active, not recruiting
- Skin Manifestations
- Karisma
-
Palermo, PA, Italy
- +1 more
Nov 21, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Malnutrition Trial in Dhaka (L- carnitine oral solution, Placebo)
Recruiting
- Malnutrition
- L- carnitine oral solution
- Placebo
-
Dhaka, BangladeshDhaka Hospital; International Centre for Diarrhoeal Disease Rese
Jan 3, 2023
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023
Chronic Pancreatitis Trial in Charleston (Prolastin-C, Placebo)
Active, not recruiting
- Chronic Pancreatitis
- Prolastin-C
- Placebo
-
Charleston, South CarolinaMedical University of South Carolina
Mar 23, 2022
Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,
Active, not recruiting
- Estrogen Receptor Negative
- +15 more
- Cyclophosphamide
- +6 more
-
Bellevue, Nebraska
- +3 more
Nov 30, 2022
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance
Not yet recruiting
- Metastatic Leiomyosarcoma
- +5 more
- Computed Tomography
- +3 more
- (no location specified)
Feb 2, 2023
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +6 more
- (no location specified)
Jan 14, 2023